Abstract: A digital communication module for a self-contained medical device communication platform is disclosed herein. In an example, a digital communication module is communicatively coupled to a therapy module of a medical device for relaying medical device data to an electronic medical record (“EMR”) server that is connected to a medical network. The digital communication module is connected to at least one other digital communication module via a wireless proprietary network that is separate from the medical network. The digital communication module determines that the medical device data from the medical device is to be transmitted, via the wireless proprietary network, to one of the other digital communication modules that is connected to the EMR server via the medical network. The other of the digital communication modules receives, and then routes the medical device data to the EMR server via the medical network.

Abstract: A system, methods, and apparatus having a circular buffer for the reply of renal therapy machine alarms and events are disclosed. An example renal therapy apparatus includes a therapy operations processor configured to generate alarms, events, and high fidelity medical device data. The renal therapy apparatus also includes a memory device having a circular buffer configured to store a duration of medical device data. The renal therapy apparatus further includes a control processor configured to receive a stream of medical device data from the therapy operations processor, and write the stream to the circular buffer such that a most recent duration of the stream is stored. The control processor is also configured to detect an occurrence of an alarm or event, and create a reply record that includes an identifier of the alarm or event and the medical device data that is stored in the circular buffer.

Abstract: A digital communication module for a self-contained medical device communication platform is disclosed herein. In an example, a digital communication module is communicatively coupled to a therapy module of a medical device for relaying medical device data to an electronic medical record (“EMR”) server that is connected to a medical network. The digital communication module is connected to at least one other digital communication module via a wireless proprietary network that is separate from the medical network. The digital communication module determines that the medical device data from the medical device is to be transmitted, via the wireless proprietary network, to one of the other digital communication modules that is connected to the EMR server via the medical network. The other of the digital communication modules receives, and then routes the medical device data to the EMR server via the medical network.

Abstract: An extracorporeal and drug delivery system includes (i) a renal failure therapy machine operable with a blood filter in fluid communication with an arterial line and a venous line, the machine including (a) an effluent pump for pumping effluent from the blood filter at an effluent flowrate, and at least one of (b) a dialysis fluid pump for pumping dialysis fluid to the blood filter at a dialysis fluid flowrate, (c) a predilution pump for pumping replacement fluid into the arterial line at a predilution flowrate, or (d) a postdilution pump for pumping replacement fluid into the venous line at a postdilution flowrate; (ii) an infusion pump operable to deliver an intravenous (“IV”) drug to the patient at an IV drug flowrate; and (iii) a coordinating logic implementor configured to adjust the IV drug flowrate based on an amount of the IV drug removed via the effluent flowrate.

Abstract: The present invention concerns an implantable access device and a method for preparing the device. According to the invention the device comprises a shape memory base structure with a biological substructure suitable for cell adhesion, cell engraftment and proliferation for use in transferring and transporting fluid mixtures (blood, suspensions, drug formulations, emulsions, cell suspensions) in/into/out of a human or animal body.

Abstract: A method, control module and extracorporeal blood treatment apparatus are provided for transferring data from said extracorporeal blood treatment apparatus. Data is retrieved pertaining to an operation of the apparatus, the data is encoded into a machine readable graphical representation for decoding at a remote server to recover the retrieved data and displaying the machine readable graphical representation as an image on the display to allow capture of the displayed image with an image capturing device and transmission of the image from the image capturing device to a remote server over a communication channel.

Abstract: The present disclosure relates to a biocompatible polymer composition for an article comprising a surface intended to contact blood, tissue, skin, epithelial layers, wounds, cells in culture fluids, body fluids, dialysis fluids, therapeutic fluids, or mixtures thereof for removal or infusion. The invention also relates to a method for the preparation of an article comprising the biocompatible polymer composition and a use thereof.

Abstract: A machine (1) for extracorporeal blood treatment comprises a device (2) for ultrafiltration of a liquid through a semi-permeable membrane (3) of a blood treatment device (4), a first sensor (11) for ultrafiltration rate through the membrane, a second group of sensors (13) for measuring a trans-membrane pressure, an infusion line (16) with an infusion pump (17) and a programmed controller (14) for calculating a maximum infusion rate as a function of the transmembrane pressure. The machine is suitable for kidney failure treatments, such as hemofiltration and hemodiafiltration. In a relatively short time the machine enables a large quantity of corporeal blood to be removed from the patient.

Abstract: A method, control module and extracorporeal blood treatment apparatus are provided for transferring data from said extracorporeal blood treatment apparatus. Data is retrieved pertaining to an operation of the apparatus, the data is encoded into a machine readable graphical representation for decoding at a remote server to recover the retrieved data and displaying the machine readable graphical representation as an image on the display to allow capture of the displayed image with an image capturing device and transmission of the image from the image capturing device to a remote server over a communication channel.

Abstract: A machine (1) for extracorporeal blood treatment comprises a device (2) for ultrafiltration of a liquid through a semi-permeable membrane (3) of a blood treatment device (4), a first sensor (11) for ultrafiltration rate through the membrane, a second group of sensors (13) for measuring a trans-membrane pressure, an infusion line (16) with an infusion pump (17) and a programmed controller (14) for calculating a maximum infusion rate as a function of the transmembrane pressure. The machine is suitable for kidney failure treatments, such as hemofiltration and hemodiafiltration. In a relatively short time the machine enables a large quantity of corporeal blood to be removed from the patient.

Abstract: A machine (1) for extracorporeal blood treatment comprises a device (2) for ultrafiltration of a liquid through a semi-permeable membrane (3) of a blood treatment device (4), a first sensor (11) for ultrafiltration rate through the membrane, a second group of sensors (13) for measuring a trans-membrane pressure, and a programmed controller (14) for calculating a maximum ultrafiltration rate as a function of the transmembrane pressure. The machine is suitable for kidney failure treatments, such as hemofiltration and hemodiafiltration. In a relatively short time the machine enables a large quantity of corporeal blood to be removed from the patient.

Abstract: The present invention concerns an implantable access device and a method for preparing the device. According to the invention the device comprises a shape memory base structure with a biological substructure suitable for cell adhesion, cell engraftment and proliferation for use in transferring and transporting fluid mixtures (blood, suspensions, drug formulations, emulsions, cell suspensions) in/into/out of a human or animal body.

Abstract: A polymer affinity matrix for the binding of one or more substances in a fluid or removing said substance(s) from the fluid and/or decreasing the amount or concentration thereof in said fluid with a view to preventing, eliminating or reducing undesired activation of components in said fluid is described, as well as a method for removing said substance(s) from the fluid and/or decreasing the amount or concentration thereof in said fluid, a method for the production of said matrix, use of said matrix and a kit comprising said matrix. The polymer affinity matrix comprises a solid support, a spacer and a ligand, containing arginine as a binding unit.

Abstract: A machine (1) for extracorporeal blood treatment comprises a device (2) for ultrafiltration of a liquid through a semi-permeable membrane (3) of a blood treatment device (4), a first sensor (11) for ultrafiltration rate through the membrane, a second group of sensors (13) for measuring a trans-membrane pressure, and a programmed controller (14) for calculating a maximum ultrafiltration rate as a function of the transmembrane pressure. The machine is suitable for kidney failure treatments, such as hemofiltration and hemodiafiltration. In a relatively short time the machine enables a large quantity of corporeal blood to be removed from the patient.

Abstract: The present disclosure relates to a biocompatible polymer composition for an article comprising a surface intended to contact blood, tissue, skin, epithelial layers, wounds, cells in culture fluids, body fluids, dialysis fluids, therapeutic fluids, or mixtures thereof for removal or infusion. The invention also relates to a method for the preparation of an article comprising the biocompatible polymer composition and a use thereof.

Abstract: A polymer affinity matrix for the binding of one or more substances in a fluid for removing said substance(s) from the fluid and/or decreasing the amount or concentration thereof in said fluid with a view to preventing, eliminating, or reducing undesired activation of components in said fluid is described, as well as a method for removing said substance(s) from the fluid and/or decreasing the amount or concentration thereof in said fluid, a method for the production of said matrix, use of said matrix and a kit comprising said matrix. The polymer affinity matrix comprises a solid support, a space and a ligand, containing arginine as a binding unit.